Twitxy Saved

Bio Stocks™

Verified account This account is verified. Learn more

@BioStocks

Investor/trader focused primarily in the biopharma sector.
Tweets are not investment advice and are not recommendations of any kind.
Toronto Joined February 2010
93 Following 73K Followers 62K Posts

Latest posts 5

Pinned post

Bio Stocks™ Verified account @BioStocks
Big Pharma M&A set for mega year as patent expiries drive deal urgency. $XBI $IBB

If the current pace holds, 2026 biopharma M&A could top $250 billion, making it the #2 year on record after 2019’s $328 billion. #biotech

ca.finance.yahoo.com/news/big-pharm…
ca.finance.yahoo.com Big Pharma M&A set for mega year as patent expiries drive deal urgency By Christy Santhosh and Sriparna Roy May 1 (Reuters) - Biotech dealmaking is on pace for a bumper year in 2026, with large drugmakers on an acquisition spree to boost their pipelines ahead of upcoming
5 replies 11 reposts 56 likes 47K views View on X